ClinVar Miner

Submissions for variant NM_000548.5(TSC2):c.5234_5241del (p.Arg1745fs)

dbSNP: rs2091147162
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001065329 SCV001230285 pathogenic Tuberous sclerosis 2 2019-04-29 criteria provided, single submitter clinical testing This sequence change results in a premature translational stop signal in the TSC2 gene (p.Arg1745Glnfs*27). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 63 amino acids of the TSC2 protein. This variant is not present in population databases (ExAC no frequency). This variant has been observed to be de novo in an individual affected with tuberous sclerosis complex (Invitae). This variant disrupts amino acid residues 1746-1751 in TSC2. Deletion of these amino acids (p.His1746_Arg1751del) has been determined to be pathogenic (PMID: 10205261, 15874888, 15024740, 9829910, 11112665, 16114042, 21520333, 21309039). As a result, variants that disrupt these residues are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.